BYKAHEPAR
BYKAHEPAR
Not authorised
- Clanobutin sodium
Product identification
Medicine name:
BYKAHEPAR
Active substance:
- Clanobutin sodium
Target species:
-
Dog
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Clanobutin sodium106.40/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA16QA05
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
France
Package description:
- Available only in French
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Intervet
Marketing authorisation date:
Manufacturing sites for batch release:
- Trirx Segre
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/9758486 7/1982
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 4/04/2022
